Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance-Reference-Cited by-同舟云学术

Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance

Published:2019-11-15 Issue:22 Volume:3 Page:3515-3521
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Hollenhorst Marie A.¹^ORCID,Al-Samkari Hanny²^ORCID,Kuter David J.²

Affiliation:

1. Division of Hematology, Stanford University School of Medicine, Stanford, CA; and

2. Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Abstract

Key Points There is a high prevalence of autoimmune markers in patients with ITP. An increased risk of thrombosis was observed in patients with ITP with a positive lupus anticoagulant or antinuclear antibody.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/3/22/3515/1539597/advancesadv2019000400.pdf

Reference30 articles.

1. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP;McMillan;Blood,2004

2. T cells in the pathogenesis of immune thrombocytopenia;Wei;Semin Hematol,2016

3. Is ITP a thrombophilic disorder?;Rodeghiero;Am J Hematol,2016

4. Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset;Vantelon;Thromb Haemost,2000

5. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia;Neunert;Blood,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The causal relationship between inflammatory cytokines and thrombocytopenia: A bidirectional two-sample Mendelian randomization study;2024-09-13

2. The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?;Thrombosis Research;2024-09

3. Pediatric Immune Thrombocytopenia: The Impact of Antithyroid Antibodies on the Treatment Outcomes;Clinical Pediatrics;2024-06-19

4. Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes;Research and Practice in Thrombosis and Haemostasis;2024-01

5. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently;Frontiers in Cardiovascular Medicine;2023-12-14